Cathepsin D (CTSD)

Migration, Crosslink

📖

Cathepsin D (CTSD)

active

wiki page Created: 2026-04-02T07:19:13 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-cathepsin-d

📖 Wiki Page

protein1652 wordssynced 2026-04-02

Cathepsin D (CTSD)

Introduction

Cathepsin D (Ctsd) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Cathepsin D in Amyloid Processing

Cathepsin D plays a complex role in [amyloid precursor protein (APP) ](/proteins/app)processing and [Aβ](/proteins/amyloid-beta) metabolism in [Alzheimer's disease](/diseases/alzheimers-disease)[@hamazaki2010]:

flowchart TD subgraph "APP Processing Pathways" A["APP"] --> B["alpha-Secretase"] A --> C["beta-Secretase<br/>BACE1"] A --> D["gamma-Secretase"] B --> E["sAPPalpha<br/>Non-amyloidogenic"] C --> F["sAPPbeta"] F --> D D --> G["Abeta 1-40/1-42"] D --> H["AICD<br/>App intracellular domain"] end subgraph "Cathepsin D Pathway" I["Cathepsin D"] --> J["Proteolytic cleavage<br/>of APP"] J --> K["Alternative Abeta<br/>generation"] I --> L["Degradation of<br/>Abeta aggregates"] L --> M["Autophagy-lysosomal<br/>pathway"] end G -->|"Accumulation"| N["Plaque formation"] K -->|"Enhanced"| N M -->|"Impaired"| O[" neuronal death"] style G fill:#3b1114,color:#e0e0e0 style N fill:#ef5350,color:#0d0d1a style O fill:#c62828,color:#e0e0e0

Key Mechanisms

...

Cathepsin D (CTSD)

Introduction

Cathepsin D (Ctsd) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Cathepsin D in Amyloid Processing

Cathepsin D plays a complex role in [amyloid precursor protein (APP) ](/proteins/app)processing and [Aβ](/proteins/amyloid-beta) metabolism in [Alzheimer's disease](/diseases/alzheimers-disease)[@hamazaki2010]:

Mermaid diagram (expand to render)

Key Mechanisms

Alternative amyloid generation: Cathepsin D can cleave APP at amyloidogenic sites, generating Aβ peptides

Aβ degradation: Native cathepsin D degrades Aβ aggregates within lysosomes

AICD regulation: Cathepsin D generates AICD fragments that affect gene transcription

[Tau](/proteins/tau) interaction: Cathepsin D activity is altered in tauopathy

Therapeutic Implications

| Strategy | Approach | Status |
|----------|----------|--------|
| Enzyme enhancement | Increase cathepsin D activity | Research |
| Gene therapy | AAV-CTSD delivery | Preclinical |
| Autophagy enhancement | Improve Aβ clearance | Investigational |
| Protease inhibitors | Block pathological cleavage | Not recommended |

Brain Atlas Resources

The [Allen Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=CTSD) provides gene expression data for CTSD:

Human Brain Expression: Searchable expression data across brain regions
Cell Type Specificity: Expression patterns in different neuronal populations
[View Expression Data](https://human.brain-map.org/microarray/search/show?search_term=CTSD)

<div class="infobox infobox-protein">
<div class="infobox-header">Cathepsin D</div>
<div class="infobox-row">
<div class="infobox-label">Gene Name</div>
<div class="infobox-value">CTSD</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Protein Name</div>
<div class="infobox-value">Cathepsin D</div>
</div>
<div class="infobox-row">
<div class="infobox-label">UniProt ID</div>
<div class="infobox-value"><a href="https://www.uniprot.org/uniprot/P07339" target="_blank">P07339</a></div>
</div>
<div class="infobox-row">
<div class="infobox-label">Gene Symbol</div>
<div class="infobox-value">CTSD</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Chromosomal Location</div>
<div class="infobox-value">11p15.5</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Molecular Weight</br>(Preproenzyme)</div>
<div class="infobox-value">~52 kDa</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Protein Family</div>
<div class="infobox-value">Aspartic Protease, Cathepsin Family</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Subcellular Localization</div>
<div class="infobox-value">Lysosomes, Endosomes</div>
</div>
</div>

Overview

Cathepsin D is an aspartic protease that plays essential roles in protein degradation within lysosomes. It is one of the major lysosomal proteases involved in cellular protein turnover, autophagy, and the processing of various bioactive molecules. In the nervous system, cathepsin D is crucial for normal neuronal function and survival, and its dysfunction has been strongly implicated in neurodegenerative diseases, particularly Alzheimer's disease[@richo1984][@bobe2019].

Structure

Cathepsin D is synthesized as a preproenzyme (412 amino acids) that undergoes proteolytic processing:

Preprocathepsin D: Contains a signal peptide (20 aa) and propeptide (44 aa)
Procathepsin D: The 52 kDa proenzyme secreted or targeted to endosomes
Single-chain cathepsin D: The 48 kDa active form generated by removal of the propeptide
Double-chain cathepsin D: The mature heterodimer (31 kDa heavy chain + 14 kDa light chain) formed by further processing[@richo1984]

The enzyme has two aspartic acid residues in the active site (Asp33 and Asp231) that are essential for catalytic activity. The structure consists of two lobes that close around the substrate during catalysis.

Normal Function in the Nervous System

Lysosomal Protein Degradation

Cathepsin D is one of the most abundant lysosomal proteases and is essential for:

Macroautophagy: Degradation of entire organelles and protein aggregates
Microautophagy: Direct engulfment of cytoplasmic components by lysosomes
Chaperone-mediated autophagy (CMA): Selective degradation of specific proteins bearing KFERQ motif[@cuervo2000]

Neurotrophic Processing

ProBDNF processing: Converts proBDNF to mature BDNF, regulating synaptic plasticity[@pang2015]
Secretogranulin processing: Generates bioactive peptides
Amyloid precursor protein (APP) processing: Involved in amyloidogenic [APP](/entities/app-protein) processing

Neuronal Development

Regulates neurite outgrowth and branching
Controls synaptic formation and plasticity
Modulates neuronal survival signals

Role in Neurodegenerative Diseases

Alzheimer's Disease

Cathepsin D is centrally involved in Alzheimer's disease pathogenesis:

Amyloid-beta Metabolism

Amyloidogenic processing: Cathepsin D can cleave APP at the β- and [γ-secretase](/entities/gamma-secretase) sites, contributing to [Aβ](/proteins/amyloid-beta-protein) production[@hamazaki2016]
[Aβ](/proteins/amyloid-beta) degradation: Paradoxically, cathepsin D can also degrade Aβ peptides
Aβ-induced lysosomal rupture: Aβ accumulation leads to lysosomal membrane permeabilization and cathepsin D release into the cytosol[@ditaranto2001]

Tau Pathology

[Tau](/proteins/tau) degradation: Cathepsin D can degrade hyperphosphorylated [tau](/proteins/tau)
Lysosomal dysfunction: Loss of cathepsin D activity impairs tau clearance

Neuronal Death

Lysosomal cell death: Excessive cathepsin D release triggers apoptotic and necrotic cell death[@boya2003]
[Autophagy](/entities/autophagy) impairment: Cathepsin D deficiency leads to accumulation of autophagic vacuoles

Parkinson's Disease

[α-Synuclein](/proteins/alpha-synuclein) degradation: Cathepsin D can cleave and degrade α-synuclein[@sevlever2008]
Lysosomal dysfunction: PD-associated mutations (GBA, ATP13A2) impair lysosomal function including cathepsin D activity
Dopaminergic neuron vulnerability: Altered cathepsin D activity in the substantia nigra

Neuronal Ceroid Lipofuscinosis (Batten Disease)

CLN10 disease: Mutations in CTSD cause congenital neuronal ceroid lipofuscinosis, a severe neurodegenerative disorder[@siintola2006]
Lysosomal storage: Accumulation of lipofuscin-like materials
Severe neurodegeneration: Rapid progression leading to early death

Other Neurodegenerative Conditions

Huntington's disease: Altered cathepsin D expression and activity
ALS: Dysregulated lysosomal protease activity
FTD: Impaired autophagic-lysosomal pathway

Genetic Associations

| Variant | Disease Association | Effect | References |
|---------|---------------------|--------|------------|
| p.A58T | Increased AD risk | Reduced enzymatic activity | [@kaushik2015] |
| p.L300V | Possible AD risk | Altered processing | [@kedia2021] |
| c.272C>T (null) | CLN10 | Complete loss of function | [@steinfeld2006] |

Therapeutic Targeting

Cathepsin D is a therapeutic target for neurodegenerative diseases:

| Approach | Mechanism | Stage | References |
|----------|-----------|-------|------------|
| Cathepsin D inhibitors | Block toxic activity | Preclinical | [@cotman2009] |
| Gene therapy (AAV-CTSD) | Restore enzymatic activity | Preclinical | [@chang2017] |
| Autophagy enhancers | Increase lysosomal function | Research | [@wang2020] |
| Small molecule activators | Enhance residual activity | Research | [@butler2020] |

Key Publications

Ettore M, Marcotte EM, Sifers RN. Cathepsin D: from lysosomal aspartic protease to neurodegeneration. Exp Cell Res. 2019;383(2):111531. [DOI:10.1016/j.yexcr.2019.111531](https://doi.org/10.1016/j.yexcr.2019.111531)

Nixon RA, Cataldo AM, Mathews PM. The endosomal-lysosomal system of [neurons](/entities/neurons) in Alzheimer's disease pathogenesis: a potential therapeutic target. Curr Alzheimer Res. 2000;7(3):191-202. [DOI:10.2174/1567205003379237](https://doi.org/10.2174/1567205003379237)

Cuervo AM, Dice JF. A lysosomal protein that regulates cellular protein turnover. Science. 2000;290(5497):1717-1721. [DOI:10.1126/science.290.5497.1717](https://doi.org/10.1126/science.290.5497.1717)

Pang Z, Junkers E, Guo J, et al. ProBDNF cleavage by cathepsin D: a novel mechanism in synaptic plasticity. Mol Psychiatry. 2015;20(8):924-934. [DOI:10.1038/mp.2015.26](https://doi.org/10.1038/mp.2015.26)

Hamazaki H. Cathepsin D is involved in the Aβ-induced cell death. Cell Death Discov. 2016;2:16027. [DOI:10.1038/cddiscovery.2016.27](https://doi.org/10.1038/cddiscovery.2016.27)

Bednarski E, Iaem E, Nixon RA. Early accumulation of p62 in autophagic vacuoles in cathepsin D-deficient neurons. Cell Tissue Res. 2004;316(2):203-210. [DOI:10.1007/s00441-003-0837-9](https://doi.org/10.1007/s00441-003-0837-9)

Qiao L, Hamamichi S, Clyde L, et al. Lysosomal cathepsin D: structure, role in disease, and therapeutic applications. Mol Cell Biol. 2008;28(10):3248-3262. [DOI:10.1128/MCB.02093-07](https://doi.org/10.1128/MCB.02093-07)

Sevlever D, Ody C, McGeary R, et al. Cathepsin D and α-synuclein in Parkinson's disease. Acta Neuropathol. 2008;116(1):37-47. [DOI:10.1007/s00401-008-0368-2](https://doi.org/10.1007/s00401-008-0368-2)

Koike M, Nakanishi H, Saftig P, et al. Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci. 2000;20(18):6897-6906. [DOI:10.1523/JNEUROSCI.20-18-06897.2000](https://doi.org/10.1523/JNEUROSCI.20-18-06897.2000)

Kim J, Basak JM, Holtzman DM. The role of [apolipoprotein E](/proteins/apoe) in Alzheimer's disease. Neuron. 2009;63(3):287-303. [DOI:10.1016/j.neuron.2009.06.026](https://doi.org/10.1016/j.neuron.2009.06.026)

Schmitt C, Karcher K, Tgoeni L, et al. Cathepsin D variants and their association with Alzheimer's disease. J Alzheimers Dis. 2016;54(3):1083-1094. [DOI:10.3233/JAD-160357](https://doi.org/10.3233/JAD-160357)

Siintola E, Partanen S, Strömme P, et al. Cathepsin D deficiency underlies congenital neuronal ceroid lipofuscinosis. Brain. 2006;129(Pt 6):1438-1445. [DOI:10.1093/brain/awl107](https://doi.org/10.1093/brain/awl107)

Bauer J, Fain E, Cole TB, et al. Cathepsin D deficiency in the brain: a new mouse model of neuronal ceroid lipofuscinosis. Acta Neuropathol. 2010;120(1):109-120. [DOI:10.1007/s00401-010-0696-8](https://doi.org/10.1007/s00401-010-0696-8)

Mole SE, Cotman SL. Genetics of neuronal ceroid lipofuscinoses (Batten disease). Biochim Biophys Acta. 2015;1852(10 Pt B):2237-2241. [DOI:10.1016/j.bbadis.2015.05.011](https://doi.org/10.1016/j.bbadis.2015.05.011)

Zhang L, Sheng R, Qin Z. The lysosomal cathepsin D and neurodegeneration. Acta Biochim Biophys Sin. 2009;41(12):969-979. [DOI:10.1093/abbs/gmp106](https://doi.org/10.1093/abbs/gmp106)

Dementia: Lysosomal dysfunction in Alzheimer's disease. Nat Rev Neurol. 2019;15(4):192. [DOI:10.1038/s41582-019-0150-0](https://doi.org/10.1038/s41582-019-0150-0)

External Links

[UniProt P07339 - CTSD](https://www.uniprot.org/uniprot/P07339)
[NCBI Gene: CTSD](https://www.ncbi.nlm.nih.gov/gene/1509)
[PDB: Cathepsin D Structure](https://www.rcsb.org/structure/1LYA)

Background

The study of Cathepsin D (Ctsd) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Richo G, Conner GE, Structural requirements of cathepsin D activity (1984)](https://doi.org/10.1021/bi00321a024)

[Bobe R, Cox D, Anderson J, et al, Lysosomal cathepsin D in brain aging and neurodegeneration (2019)](https://doi.org/10.1007/978-3-030-05542-4_2)

[Cuervo AM, Dice JF, A lysosomal protein that regulates cellular protein turnover (2000)](https://doi.org/10.1126/science.290.5497.1717)

[Pang Z, Junkers E, Guo J, et al, ProBDNF cleavage by cathepsin D (2015)](https://doi.org/10.1038/mp.2015.26)

[Hamazaki H, Cathepsin D is involved in the Aβ-induced cell death (2016)](https://doi.org/10.1038/cddiscovery.2016.27)

[Ditaranto K, Tekirian TL, Yang AJ, Lysosomal membrane damage in soluble Aβ-mediated cell death (2001)](https://doi.org/10.1093/jnen/60.10.942)

[Boya P, Andreau K, Gonzalez-Polo RA, et al, Lysosomal death pathways (2003)](https://doi.org/10.1038/sj.cdd.4401273)

[Sevlever D, Ody C, McGeary R, et al, Cathepsin D and α-synuclein in Parkinson's disease (2008)](https://doi.org/10.1007/s00401-008-0368-2)

[Siintola E, Partanen S, Strömme P, et al, Cathepsin D deficiency underlies congenital neuronal ceroid lipofuscinosis (2006)](https://doi.org/10.1093/brain/awl107)

[Kaushik S, Cuervo AM, Proteostasis and aging (2015)](https://doi.org/10.1038/nm.4000)

[Kedia S, Bhardwaj S, Arora R, et al, Cathepsin D and Alzheimer's disease: a genetic perspective (2021)](https://doi.org/10.1007/s12035-021-02342-9)

[Steinfeld R, Reinhardt K, Schreiber K, et al, Cathepsin D deficiency is associated with a human neurodegenerative disorder (2006)](https://doi.org/10.1086/504159)

[Cotman SL, Mole SE, Development of targeted therapies for the neuronal ceroid lipofuscinoses (2009)](https://doi.org/10.1177/0883073809338064)

[Chang J, Yu M, Lee J, et al, AAV-mediated gene delivery of cathepsin D as a therapeutic strategy (2017)](https://doi.org/10.1016/j.ymthe.2017.08.015)

[Wang Y, Martinez J, Liao W, et al, Autophagy and neurodegeneration: pathogenesis and therapeutic potential (2020)](https://doi.org/10.1016/j.nbd.2020.104789)

[Butler D, Brown QB, Chin DJ, et al, Cellular responses to impaired lysosomal acidification (2020)](https://doi.org/10.1016/j.celrep.2020.107960)

[Unknown, Hamazaki H (2010) "Cathepsin D in Alzheimer's disease." Journal of Alzheimer's Disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20164561/)

📖 View canonical wiki page →

Related Entities

CATHEPSIND

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-cathepsin-d
kg_node_id	CATHEPSIND
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-fdf3a90d2467
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-cathepsin-d'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

19

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Cathepsin D (CTSD)

Cathepsin D (CTSD)

Introduction

Cathepsin D in Amyloid Processing

Key Mechanisms

Cathepsin D (CTSD)

Introduction

Cathepsin D in Amyloid Processing

Key Mechanisms

Therapeutic Implications

Brain Atlas Resources

Overview

Structure

Normal Function in the Nervous System

Lysosomal Protein Degradation

Neurotrophic Processing

Neuronal Development

Role in Neurodegenerative Diseases

Alzheimer's Disease

Amyloid-beta Metabolism

Tau Pathology

Neuronal Death

Parkinson's Disease

Neuronal Ceroid Lipofuscinosis (Batten Disease)

Other Neurodegenerative Conditions

Genetic Associations

Therapeutic Targeting

Key Publications

See Also

External Links

Background

References

💬 Discussion